Acorda Therapeutics Provides Long-Term Business Plan and Financial Guidance
27.10.2022 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided a detailed, long-term business plan to drive shareholder value and also provided long-term financial guidance. Acorda has developed a long-term business plan to increase the value of the ...
United States Ron Cohen Exchange Commission Df King Co Inc National Coverage Data Therapy Qual Research Jan
Source: wallstreet-online.de